Kaifa Tang

Dr. Kaifa Tang

The Affiliated Hospital of Guizhou Medical University
+1
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2021 in Frontiers in Oncology
Verified
Journal Article
Open access
BCBangwei Che
Bangwei Che
WZWenjun Zhang
Wenjun Zhang
SXShenghan Xu
Shenghan Xu
JYJingju Yin
Jingju Yin
JHJun He
Jun He
KTKaifa Tang
Kaifa Tang
Although the incidence and mortality of prostate cancer have gradually begun to decline in the past few years, it is still one of the leading causes of death from malignant tumors in the world. The occurrence and development of prostate cancer are affected by race, family history, microenvironment, and other factors. In recent decades, more and more studies have confirmed that prostate microflora in the tumor microenvironment may play an important role in the occurrence, development, and prognosis of prostate cancer. Microorganisms or their metabolites may affect the occurrence and metastasis of cancer cells or regulate anti-cancer immune surveillance. In addition, the use of tumor microenvironment bacteria in interventional targeting therapy of tumors also shows a unique advantage. In this review, we introduce the pathway of microbiota into prostate cancer, focusing on the mechanism of microorganisms in tumorigenesis and development, as well as the prospect and significance of microorganisms as tumor biomarkers and tumor prevention and treatment.

1 December 2021 in Phytomedicine
Verified
Journal Article
Closed access
CZChun-Lei Zhang
Chun-Lei Zhang
JZJin-Juan Zhang
Jin-Juan Zhang
QZQin-Feng Zhu
Qin-Feng Zhu
HGHuan-Yu Guan
Huan-Yu Guan
YYYa-Xin Yang
Ya-Xin Yang
SLShanggao Liao
Shanggao Liao

17 May 2023 in Frontiers in Oncology
Verified
Journal Article
Open access
CZCheng Zha
Cheng Zha
ZPZheng Peng
Zheng Peng
KHKunyuan Huang
Kunyuan Huang
KTKaifa Tang
Kaifa Tang
QWQiang Wang
Qiang Wang
WZWenjun Zhang
Wenjun Zhang
The gut microbiota helps to reveal the relationship between diseases, but the role of gut microbiota in prostate cancer (PCa) is still unclear. Recent studies have found that the composition and abundance of specific gut microbiota are significantly different between PCa and non-PCa, and the gut microbiota may have common and unique characteristics between different diseases. Intestinal microorganisms are affected by various factors and interact with the host in a variety of ways. In the complex interaction model, the regulation of intestinal microbial metabolites and the host immune system is particularly important, and they play a key role in maintaining the ecological balance of intestinal microorganisms and metabolites. However, specific changes in the composition of intestinal microflora may promote intestinal mucosal immune imbalance, leading to the formation of tumors. Therefore, this review analyzes the immune regulation of intestinal flora and the production of metabolites, as well as their effects and mechanisms on tumors, and briefly summarizes that specific intestinal flora can play an indirect role in PCa through their metabolites, genes, immunity, and pharmacology, and directly participate in the occurrence, development, and treatment of tumors through bacterial and toxin translocation. We also discussed markers of high risk PCa for intestinal microbiota screening and the possibility of probiotic ingestion and fecal microbiota transplantation, in order to provide better treatment options for clinic patients. Finally, after summarizing a number of studies, we found that changes in immunity, metabolites.

1 March 2008 in Asian Journal of Andrology
Verified
Journal Article
Open access
QWQifei Wu
Qifei Wu
JXJun-Ping Xing
Jun-Ping Xing
KTKaifa Tang
Kaifa Tang
WXWei Xue
Wei Xue
MLMin Liu
Min Liu
XJXiao-Juan Jin
Xiao-Juan Jin
AJA publishes new findings in basic and clinical (including modern, traditional and epidemiological) research on Andrology.

5 August 2022 in Asian Journal of Andrology
Verified
Journal Article
Open access
BCBang-Wei Che
Bang-Wei Che
PCPan Chen
Pan Chen
YYYing Yu
Ying Yu
WLWei Li
Wei Li
THTao Huang
Tao Huang
KTKaifa Tang
Kaifa Tang
Coronavirus disease 2019 (COVID-19) has yet to be proven to alter male reproductive function, particularly in the majority of mild/asymptomatic patients. The purpose of this study was to explore whether mild/asymptomatic COVID-19 affects semen quality and sex-related hormone levels. To find suitable comparative studies, a systematic review and meta-analysis was done up to January 22, 2022, by using multiple databases (Web of Science, PubMed, and Embase). Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were used to identify and choose the studies. Meta-analysis was used to examine the semen parameters and sex-related hormones of mild/asymptomatic COVID-19 patients before and after infection. The effects of semen collection time, fever, and intensity of verification on semen following infection were also investigated. A total of 13 studies (n = 770) were included in the analysis, including three case-control studies, six pre-post studies, and four single-arm studies. A meta-analysis of five pre-post studies showed that after infection with COVID-19, sperm concentration (I 2 = 0; P = 0.003), total sperm count (I 2 = 46.3%; P = 0.043), progressive motility (I 2 = 50.0%; P < 0.001), total sperm motility (I 2 = 76.1%; P = 0.047), and normal sperm morphology (I 2 = 0; P = 0.001) decreased. Simultaneously, a systematic review of 13 studies found a significant relationship between semen collection time after infection, inflammation severity, and semen parameter values, with fever having only bearing on semen concentration. Furthermore, there was no significant difference in sex-related hormone levels before and after infection in mild/asymptomatic patients. Mild/asymptomatic COVID-19 infection had a significant effect on semen quality in the short term. It is recommended to avoid initiating a pregnancy during this period of time.

4 December 2014 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
HZHongyan Zhang
Hongyan Zhang
XWXuwei Wu
Xuwei Wu
YXYi Xiao
Yi Xiao
MCMei Chen
Mei Chen
ZLZhidong Li
Zhidong Li
KTKaifa Tang
Kaifa Tang
Our objective is to investigate the genetic polymorphisms of the glutathione S-transferase M1 and T1 genes (GSTM1 and GSTT1) and evaluate oxidative damage in patients with non-small lung cancer (N-SCLC). One hundred and ten patients with N-SCLC and 100 controls are included in this case-control study. Multiplex polymerase chain reaction (PCR) analyses were used to identify the genotypes. The activities of malondialdehyde (MDA) and nitric oxide (NO) and total antioxidant capacity (T-AOC) were detected by spectroscopic analysis. The frequencies of the GSTM1, T1, and GSTM1/T1 null genotypes in the patient group were significantly higher than that in the control group (OR = 2.071, P = 0.009; OR = 1.900, P = 0.024; OR = 3.258, P = 0.003). The activities of MDA and NO were significantly higher in the patient group than that in the control group (P <0.001), and T-AOC was significantly lower in patient group than that in control group (P <0.001). The activities of MDA, and NO were higher but the T-AOC was lower in patients with the GSTM1, T1 and M1/T1 null genotypes than those in patients with GSTM1, T1 and M1/T1 present genotypes (P <0.001). Our results suggest that oxidative damage may be play a important role in patients with N-SCLC, and that GSTM1 and GSTT1 null genotypes may predispose the cells of patients with N-SCLC to increased oxidative damage.